Contact us: +91 9550333722 040 - 40102781
Structured search
India
Choose your country
Different countries will display different contents
Try our best to find the right business for you.
My chemicalbook

Welcome back!

HomeProduct name listSolifenacin

Solifenacin

Solifenacin Structural

What is Solifenacin?

Absorption

Solifenacin is well absorbed in the duodenum, jejunum, and ileum but not the stomach. Absorption occurs via passive diffusion and so no transporters are involved. The mean oral bioavailability of solifenacin is 88%. The Tmax of solifenacin is 3-8 hours with a Css of 32.3ng/mL for a 5mg oral dose and 62.9ng/mL for a 10mg oral dose.

Toxicity

The LD50 of Solifenacin has yet to be determined.
Signs of overdose include severe anticholinergic effects, mental status changes, and decreased consciousness. In case of overdose, treat patients with gastric lavage and supportive measures. Monitor patients with an ECG.

The Uses of Solifenacin

muscarinic M3 antagonist

Indications

Solifenacin tablets are indicated to treat an overactive bladder with urinary incontinence, urgency, and frequency.

Background

Solifenacin is a competitive muscarinic receptor antagonist indicated to treat an overactive bladder with urinary incontinence, urgency, and frequency. It has a long duration of action as it is usually taken once daily.
Solifenacin was granted FDA approval on 19 November 2004.

Definition

ChEBI: Solifenacin is a member of isoquinolines.

brand name

Vesicare (Astellas).

Pharmacokinetics

Solifenacin antagonizes the M2 and M3 muscarinic receptors in the bladder to treat an overactive bladder. It has a long duration of action as it is usually taken once daily. Patients taking solifenacin should be aware of the risks of angioedema and anaphylaxis.

Metabolism

Solifenacin undergoes N-oxidation at the quinuclidin ring by cytochrome P450, though the exact enzymes are not revealed in the literature. The tetrahydroisoquinolone ring is 4R-hydroxylated by CYP3A4, CYP1A1, and CYP2D6. A 4R-hydroxy N-oxide metabolite is also formed by CYP3A4. Finally, solifenacin can undergo direct glucuronidation. Only solifenacin and the 4R-hydroxy metabolite are pharmacologically active.

Properties of Solifenacin

Boiling point: 505.5±50.0 °C(Predicted)
Density  1.24±0.1 g/cm3(Predicted)
storage temp.  Store at -20°C
solubility  DMSO : ≥ 50 mg/mL (137.95 mM);Water : < 0.1 mg/mL (insoluble)
form  Solid
pka 9.03±0.33(Predicted)
color  White to off-white

Safety information for Solifenacin

Signal word Warning
Pictogram(s)
ghs
Exclamation Mark
Irritant
GHS07
GHS Hazard Statements H302:Acute toxicity,oral
H315:Skin corrosion/irritation
H319:Serious eye damage/eye irritation
H335:Specific target organ toxicity, single exposure;Respiratory tract irritation
Precautionary Statement Codes P261:Avoid breathing dust/fume/gas/mist/vapours/spray.
P264:Wash hands thoroughly after handling.
P264:Wash skin thouroughly after handling.
P270:Do not eat, drink or smoke when using this product.
P271:Use only outdoors or in a well-ventilated area.
P280:Wear protective gloves/protective clothing/eye protection/face protection.
P330:Rinse mouth.
P362:Take off contaminated clothing and wash before reuse.
P301+P312:IF SWALLOWED: call a POISON CENTER or doctor/physician IF you feel unwell.
P302+P352:IF ON SKIN: wash with plenty of soap and water.
P304+P340:IF INHALED: Remove victim to fresh air and Keep at rest in a position comfortable for breathing.
P305+P351+P338:IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continuerinsing.
P332+P313:IF SKIN irritation occurs: Get medical advice/attention.
P337+P313:IF eye irritation persists: Get medical advice/attention.
P405:Store locked up.
P403+P233:Store in a well-ventilated place. Keep container tightly closed.
P501:Dispose of contents/container to..…

Computed Descriptors for Solifenacin

Related products of tetrahydrofuran

You may like

  • 242478-37-1 SolifenacinBase(1S,3’R)-3’-quinuclidinyl-1-phenyl-1,2,3,4-tetrahydro-2- isoquinolinecarboxylate(242478-37-1) 98%
    242478-37-1 SolifenacinBase(1S,3’R)-3’-quinuclidinyl-1-phenyl-1,2,3,4-tetrahydro-2- isoquinolinecarboxylate(242478-37-1) 98%
    242478-37-1
    View Details
  • Solifenacin 98%
    Solifenacin 98%
    View Details
  • Solifenacin 98%
    Solifenacin 98%
    242478-37-1
    View Details
  • Solifenacin 242478-37-1 98%
    Solifenacin 242478-37-1 98%
    242478-37-1
    View Details
  • 242478-37-1 Solifenacin 98%
    242478-37-1 Solifenacin 98%
    242478-37-1
    View Details
  • 242478-37-1 Solifenacin 99%
    242478-37-1 Solifenacin 99%
    242478-37-1
    View Details
  • 2-(3-(tert-butyl)phenoxy)-2-methylpropanoic acid 1307449-08-6 98%
    2-(3-(tert-butyl)phenoxy)-2-methylpropanoic acid 1307449-08-6 98%
    1307449-08-6
    View Details
  • Lithium Clavulanate
    Lithium Clavulanate
    61177-44-4
    View Details
Statement: All products displayed on this website are only used for non medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.